AVOIDABLE DEATHS FROM ONCOLOGY DISEASE IN AKTOBE REGION
Introduction. Population health is the primary outcome of a health care system. Measuring the performance of a health care system is essential to assessing the effectiveness of existing programs. Therefore, the aim of our study to assess the avoidable deaths from oncological disease in Aktobe region.
Materials and methods: We extracted data from the National research center for health development in Aktobe region by urban and rural area. In calculation population by age; death rates from oncologic diseases from 2019 to 2023, by gender and 5-year age group (0, 1–4, 5–9, 69) were included. Join point regression used to identify the average annual percentage change.
Results. Avoidable deaths from oncological disease decrease from 29.92 to 27.94 per 100000 population during 2019-2023. The preventable deaths from oncological diseases per 100000 populations fluctuated between 17.20 to 17.08, where the peak increase was in 2021 to 19.51, whereas treatable deaths rate decreased from 15.06 to 10.87 in studied years The avoidable deaths was higher among male and rural residents. The absolute changes were for avoidable deaths – 1.98, where preventable was -1.86 and treatable -1.98. Relative changes were -0.07, with the difference between preventable and treatable as -0.11 to -0.01.
Conclusion. The leading causes of avoidable death were colorectal and lung cancer. Despite some reduction in avoidable mortality, it remains high among rural residents and males, which requires studying the causes and developing measures among them.
Number of Views: 99
Category of articles:
Original article
Bibliography link
Katasheva D., Akhmetzhan A., Alekenova N., Akhtayeva N., Nurbaulina E. Avoidable deaths from oncology disease in Aktobe region // Ғылым және Денсаулық сақтау. 2024. Т.26 (6). Б. 28-37. doi 10.34689/SH.2024.26.6.004Related publications:
THE RELATIONSHIP BETWEEN BODY MASS INDEX AND BONE MINERAL DENSITY IN THE MIDDLE-AGED AND ELDERLY POPULATION
CLINICAL, MORPHOLOGICAL AND MORPHOMETRIC ASSESSMENT OF GRANULOMATOUS INFLAMMATION IN SARCOIDOSIS AND PULMONARY TUBERCULOSIS
DRUG-INDUCED LIVER INJURY IN HIV-INFECTED PATIENTS WITH ACTIVE TUBERCULOSIS: COMPARATIVE LABORATORY CHARACTERIZATION
RESULTS OF THE IMPLEMENTATION OF THE DISEASE MANAGEMENT PROGRAM ON CHRONIC HEART FAILURE IN THE REPUBLIC OF KAZAKHSTAN
COMORBIDITY IN OSTEOARTHRITIS